Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations

Liposome encapsulated Disulfiram inhibits NFκB pathway and targets breast cancer stem cells in vitro and in vivo

(2015) Peng Liu et al.   Oncotarget

Inhibitory effect of Disulfiram/copper complex on non-small cell lung cancer cells

(2014) Lincan Duan et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

On the interaction of copper(ii) with disulfiram

(2014) David J. Lewis et al.   CHEMICAL COMMUNICATIONS

Poly(ethyleneimine) functionalized carbon nanotubes as efficient nano-vector for transfecting mesenchymal stem cells

(2014) Hanieh Moradian et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kB pathway inhibition

(2014) Jie Zha et al.   Journal of Translational Medicine

Multi-targeted inhibition of tumor growth and lung metastasis by redox-sensitive shell crosslinked micelles loading disulfiram

(2014) Xiaopin Duan et al.   NANOTECHNOLOGY

Smart pH-Sensitive and Temporal-Controlled Polymeric Micelles for Effective Combination Therapy of Doxorubicin and Disulfiram

(2013) Xiaopin Duan et al.   ACS Nano

Azidothymidine hinders arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells by induction of p21 and attenuation of G2/M arrest

(2013) Saeed Hassani et al.   ANNALS OF HEMATOLOGY

Reply: Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells

(2013) P Liu et al.   BRITISH JOURNAL OF CANCER

Comment on ‘Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells’

(2013) B Cvek   BRITISH JOURNAL OF CANCER

Disulfiram, an old drug with new potential therapeutic uses for human hematological malignancies

(2012) Concetta Conticello et al.   INTERNATIONAL JOURNAL OF CANCER

PLGA-based nanoparticles: An overview of biomedical applications

(2012) Fabienne Danhier et al.   JOURNAL OF CONTROLLED RELEASE

Diethyldithiocarbamate complex with copper: the mechanism of action in cancer cells

(2012) Zdenek Skrott et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY

Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative disease

(2012) Daniel J O’Shannessy et al.   SpringerPlus

Disulfiram modulated ROS–MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties

(2011) N C Yip et al.   BRITISH JOURNAL OF CANCER

Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents

(2011) Rassoul Dinarvand et al.   International Journal of Nanomedicine

Targeted drug delivery to tumors: Myths, reality and possibility

(2011) You Han Bae et al.   JOURNAL OF CONTROLLED RELEASE

PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect

(2010) Sarbari Acharya et al.   ADVANCED DRUG DELIVERY REVIEWS

Disulfiram Treatment Facilitates Phosphoinositide 3-Kinase Inhibition in Human Breast Cancer Cells In vitro and In vivo

(2010) H. Zhang et al.   CANCER RESEARCH

Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth

(2010) Jianqing Lin et al.   PROSTATE

Disulfiram/copper complex inhibiting NFκB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines

(2009) Xiaoxia Guo et al.   CANCER LETTERS

High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth

(2009) K. Iljin et al.   CLINICAL CANCER RESEARCH

New uses for old copper-binding drugs: converting the pro-angiogenic copper to a specific cancer cell death inducer

(2008) Di Chen et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA–PEG–folate conjugate

(2008) Farnaz Esmaeili et al.   JOURNAL OF DRUG TARGETING